Clinical Trial Update: Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of C-CHOP in untreated angioimmunoblastic T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioimmunoblastic T-cell Lymphoma

Drugs mentioned

• C-CHOP

Snippet

Sponsor: Ruijin Hospital | Conditions: Angioimmunoblastic T-cell Lymphoma | Phase 2 | Status: UNKNOWN